Visualant Scans for Expansion Opportunities in Europe

Visualant Scans for Expansion Opportunities in Europe profile publishes days in advance of the Laser World of Photonics

SEATTLE, Wash., May 7, 2013 (GLOBE NEWSWIRE) -- via PRWEB - Visualant, Inc.
(OTCBB:VSUL), an industry-leading provider of light-based identification and
diagnostic solutions, will bring its innovative ChromaID™ technology to one of
the world's foremost photonics tradeshows, the Laser World of Photonics.

The company was recently the subject of an extensive profile in in
recognition of the company's innovative advancements in photonics led by
Chairman of Visualant's Scientific Advisory Board, Dr. Tom Furness. Dr.
Furness has been instrumental in founding 25 high technology companies, two of
which are traded on NASDAQ at a market capitalization of over $1 billion
(USD). In 1998 he received the Discover Award for his invention of the virtual
retinal display and he has made a number of television appearances including

WHO: Visualant's 'sci-fi' scanning technology will be demonstrated by Todd
Sames, VP business development. To discuss development opportunities or to
arrange an in-depth demo of ChromaID technology at the upcoming Laser Show in
Munich, please contact Todd Sames at todd.m.sames(at)visualant(dot)net.

WHAT: Visualant will demonstrate its ChromaID technology for the first time in
Europe at booth C2/657.

WHERE/WHEN: The Laser World of Photonics takes place in Munich, Germany, on
May 13th-16th, 2013.

About Visualant, Inc.

Visualant™ is a public company whose shares trade under the stock symbol,
VSUL. The Visualant Spectral Pattern Matching™ technology directs structured
light onto a substance, through a liquid/gas, or off a surface, to capture a
unique ChromaID™. When matched against existing databases, a ChromaID can be
used to identify, detect, or diagnosis markers invisible to the human eye.
ChromaID scanner modules can be integrated into a variety of mobile or
fixed-mount form factors. The patented technology is disruptive, making it
possible to effectively conduct analyses in the field that could only
previously be performed by large and expensive lab–based tests.

Visualant has a Joint Development Agreement through December 31, 2013 with
Sumitomo Precision Products Co., Ltd. ("SPP"), which focuses on the
commercialization of the SPM technology and an ongoing License Agreement
providing SPP with an exclusive license of the SPM technology in identified
Asian territories. For more information, visit

Sumitomo Precision Products Co., Ltd. is publicly traded and has operations in
Japan, United States, China, United Kingdom, Canada, and other parts of the
world. Additional information on SPP is available at


Press contact:

Hal Bringman
+1 (206) 299-0622 ext 801
+1 (310) 210-8011
Skype: halbringman

This article was originally distributed on PRWeb. For the original version
including any supplementary images or video, visit

         Hal Bringman
         (323) 851-6877
Press spacebar to pause and continue. Press esc to stop.